Literature DB >> 31691406

Vasopressin in the lateral septum decreases conditioned place preference to amphetamine and nucleus accumbens dopamine release.

Macarena F Gárate-Pérez1, Alejandra Méndez2, Carolina Bahamondes2, Claudia Sanhueza1, Fanny Guzmán3, Miguel Reyes-Parada1,4, Ramón Sotomayor-Zárate2, Georgina M Renard1.   

Abstract

The lateral septum (LS) is a limbic nucleus interconnected with several brain areas involved in the regulation of mood and reward. Vasopressin (AVP) is a neuropeptide that has been related to the effects of drugs of abuse, but its role in the addictive process is poorly understood. LS expresses a high density of AVP 1A receptors (V1A ). The aim of this work was to examine whether the modulation of LS AVP system affects the behavioral and neurochemical responses to amphetamine (AMPH) in male rats. Our results show that AMPH-induced conditioned place preference (CPP) produces a decrease in LS AVP content. Besides, we demonstrate that the microinjection of AVP in the LS impairs the expression of AMPH-induced CPP and that this effect is mediated by the activation of the V1A receptor in the LS. AVP microinjection in the LS elicited a decrease in neuronal activity in the nucleus accumbens (NAc) in animals subjected to AMPH conditioning. Finally, AVP microinjection in the LS decreased dopamine (DA) release in the NAc. Overall, our data demonstrate that intra-LS AVP diminishes the expression of AMPH conditioning behavior while decreasing neuronal activity and DA release in the NAc. Presumably, the effects of AVP in the LS produce an inhibition of GABAergic projections to the VTA, increasing local inhibitory tone in this nucleus, which in turn reduces the activity of DA projections to NAc. Thus, these results contribute to the knowledge about the role of AVP in LS in regulating the reward circuit and addictive like behaviors.
© 2019 Society for the Study of Addiction.

Entities:  

Keywords:  amphetamine; dopamine; lateral septum; nucleus accumbens; vasopressin

Year:  2019        PMID: 31691406     DOI: 10.1111/adb.12851

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  7 in total

Review 1.  Roles, molecular mechanisms, and signaling pathways of TMEMs in neurological diseases.

Authors:  Qinghong Chen; Junlin Fang; Hui Shen; Liping Chen; Mengying Shi; Xianbao Huang; Zhiwei Miao; Yating Gong
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Modafinil Administration to Preadolescent Rat Impairs Non-Selective Attention, Frontal Cortex D2 Expression and Mesolimbic GABA Levels.

Authors:  Valeska Cid-Jofré; Macarena Moreno; Ramón Sotomayor-Zárate; Gonzalo Cruz; Georgina M Renard
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

3.  Fluid intake, what's dopamine got to do with it?

Authors:  Elizabeth G Mietlicki-Baase; Jessica Santollo; Derek Daniels
Journal:  Physiol Behav       Date:  2021-04-07

4.  Brain functional networks associated with social bonding in monogamous voles.

Authors:  M Fernanda López-Gutiérrez; Zeus Gracia-Tabuenca; Juan J Ortiz; Francisco J Camacho; Larry J Young; Raúl G Paredes; Néstor F Díaz; Wendy Portillo; Sarael Alcauter
Journal:  Elife       Date:  2021-01-14       Impact factor: 8.140

Review 5.  Role of Oxytocin and Vasopressin in Neuropsychiatric Disorders: Therapeutic Potential of Agonists and Antagonists.

Authors:  Valeska Cid-Jofré; Macarena Moreno; Miguel Reyes-Parada; Georgina M Renard
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

Review 6.  The neural circuits of monogamous behavior.

Authors:  María Fernanda López-Gutiérrez; Sara Mejía-Chávez; Sarael Alcauter; Wendy Portillo
Journal:  Front Neural Circuits       Date:  2022-09-29       Impact factor: 3.342

Review 7.  Corticotropin-releasing factor system in the lateral septum: Implications in the pathophysiology of obesity.

Authors:  Rossy Olivares-Barraza; José Luis Marcos; Jonathan Martínez-Pinto; Marco Fuenzalida; Javier A Bravo; Katia Gysling; Ramón Sotomayor-Zárate
Journal:  Front Mol Neurosci       Date:  2022-09-20       Impact factor: 6.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.